"Chemokine CXCL2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is synthesized by activated MONOCYTES and NEUTROPHILS. It has specificity for CXCR2 RECEPTORS.
| Descriptor ID |
D054426
|
| MeSH Number(s) |
D12.644.276.374.200.120.100 D12.644.276.374.200.600.940 D12.776.467.374.200.120.100 D12.776.467.374.200.600.940 D23.125.300.120.100 D23.125.300.600.940 D23.469.200.120.100 D23.469.200.600.940 D23.529.374.200.120.100 D23.529.374.200.600.940
|
| Concept/Terms |
Chemokine CXCL2- Chemokine CXCL2
- CXCL2, Chemokine
- LDNCF-2
- Macrophage Inflammatory Protein 2
- Macrophage Inflammatory Protein-2alpha
- Inflammatory Protein-2alpha, Macrophage
- Macrophage Inflammatory Protein 2alpha
- Chemokine (C-X-C Motif) Ligand 2
- MIP-2alpha
- MIP 2alpha
- MIP2alpha
- CXCL2 Chemokine
- Chemokine, CXCL2
- MIP-2 Chemokine
- Chemokine, MIP-2
- MIP 2 Chemokine
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL2".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL2".
This graph shows the total number of publications written about "Chemokine CXCL2" by people in this website by year, and whether "Chemokine CXCL2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 3 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL2" by people in Profiles.
-
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme. Sci Adv. 2021 01; 7(5).
-
Molecular cloning and biophysical characterization of CXCL3 chemokine. Int J Biol Macromol. 2018 Feb; 107(Pt A):575-584.
-
Hematopoietic Stem Cell Niches Produce Lineage-Instructive Signals to Control Multipotent Progenitor Differentiation. Immunity. 2016 12 20; 45(6):1219-1231.
-
Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int. 2013 Apr; 83(4):604-14.
-
G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils. J Leukoc Biol. 2012 Dec; 92(6):1215-25.
-
CCL2 in chronic lymphocytic leukemia: a macro in microenvironment? Leuk Lymphoma. 2012 Oct; 53(10):1849-50.
-
Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population. Scand J Gastroenterol. 2011 Mar; 46(3):333-40.
-
STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction. Blood. 2010 Apr 22; 115(16):3354-63.
-
MEKK3 is required for lysophosphatidic acid-induced NF-kappaB activation. Cell Signal. 2009 Oct; 21(10):1488-94.
-
Atherogenic diet-induced hepatitis is partially dependent on murine TLR4. J Leukoc Biol. 2008 Jun; 83(6):1336-44.